Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |